Ottawa Hospital Research Institute

Crohn's

	Researchers update guidance on colorectal cancer screening in patients with IBDs November 4, 2021 - Dr. Sanjay Murthy was the lead author in a Clinical Practice Update (CPU) for the American Gastroenterological Association on how to prevent, detect and manage colorectal neoplastic lesions in patients with inflammatory bowel diseases (IBDs) based on
	Unravelling the mystery of how one gene contributes to Parkinson’s, Crohn’s and leprosy September 25, 2019 - Researchers have struggled for years to understand how mutations in one gene, called LRRK2, can increase the risk of three very different diseases: Parkinson’s (a brain disease), Crohn’s (a gut disease) and leprosy (a peripheral nervous system diseas
	Are we using biologic therapy properly? June 13, 2019 - The introduction of infliximab (Remicade), the first biologic therapy approved for the treatment of inflammatory bowel diseases (IBD), did not result in lower rates of hospitalizations or intestinal surgeries among patients living with IBD in Ontario

Name	Scientific appointment	Diseases, conditions and populations of interest	Research and clinical approaches
Murthy, Sanjay MD, FRCPC	Scientist (ICD)	Colorectal cancer, Crohn's, Gastrointestinal disease, Inflammatory bowel syndrome	Clinical decision rules, Clinical research, Cohort studies, Epidemiology, Health economics, Health services research
Schlossmacher, Michael MD, DABPN, FRCPC	Program Director and Senior Scientist (NS)	Aging, Brain and neuromuscular disease, Crohn's, Dementia, Inflammatory bowel syndrome, Dementia, Parkinson's	Basic research, Biomarkers, Cohort studies, Disease models, Drug development, Genetics, Lipidomics, Molecular and cellular biology, Proteomics, Risk assessment, Transgenic/knockout models, Translational research

Search for clinical trials at The Ottawa Hospital related to this disease or condition.